Recent Updates
Recently added Catalysts
KIDS Positive Sentiment

OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 27, 2026

Key Takeaway: OrthoPediatrics Corp. has announced the release date for its third quarter 2026 financial results, which is set for October 27, 2026, after market close. The company will also host a conference call on the same day at 4:30 p.m. ET to discuss these results. Investors can access the call via a live and archived webcast.

Market Sentiment Analysis

POSITIVE FACTORS

  • OrthoPediatrics is focused on advancing pediatric orthopedics.
  • The company has a comprehensive product offering for pediatric orthopedic conditions.
  • Scheduled financial results indicate transparency and communication with investors.

Full Press Release Details

WARSAW, Ind., Oct. 13, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2026 financial results on Tuesday, October 27, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, October 27, 2026 at 4:30 p.m. ET to discuss the results.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.
About OrthoPediatrics Corp. Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 95 systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.

Investor Contact Philip Trip Taylor Gilmartin Group philip@gilmartinir.com 415-937-5406

Frequently Asked Questions

When will OrthoPediatrics report its Q3 2026 results?

OrthoPediatrics will report its Q3 2026 financial results on October 27, 2026.

What time is the conference call for Q3 results?

The conference call will take place at 4:30 p.m. ET on October 27, 2026.

How can investors access the conference call?

Investors can access the call via a live and archived webcast on the OrthoPediatrics website.

What products does OrthoPediatrics offer?

OrthoPediatrics offers over 95 systems for pediatric orthopedic conditions.

Last updated: Oct 13, 2026